Skip to main content

Malawi Government Urges Cannabis Farmers To Form Collectives

The country’s minister of Agriculture has urged cannabis farmers to form cooperatives to increase their bargaining power.

In yet another sign that the African continent is shaping up to be a power player in the world of international cannabis, Lobin Lowe, the Minister of Agriculture, has urged domestic cannabis cultivators to work together to increase their leverage (and pricing). Lowe is supportive of including cannabis as a critical part of the country’s agricultural export strategy to help build domestic development.

The Minister’s remarks came during a training workshop for farmers.

The focus here will be to create regulated products that can be exported to markets that require certifications (like the European medical market). Uncertified cultivations, however, will still be illegal.

Ready, Set, License?

So far, the government has issued 72 licenses to both local and international companies. 

However, the government is also considering issuing special licenses to local farmers so that Malawians can benefit from the crop locally.

The differentiation between cannabis for export and that grown domestically for local consumption is one that has been growing steadily over the last couple of years – and is a global phenom.

Holland is one example of the same in Europe, as is the Czech Republic. In Thailand, medical crops for domestic use are grown by farmers who are not complying with EU-GMP standards but are delivering it direct to domestic hospitals.

This dichotomy may become more widespread in places where capital is scarce (such as the developing world) and as another issue enters the room – namely recreational reform.

Regardless, the idea of cannabis as both export crop and domestic cultivar for the benefit of local citizens is one that is spreading, particularly as cannabis access becomes normalized.

Democratic access to the plant, regardless of resources to pay, is a discussion that is also clearly in the room. This is not a drug of the 1%, even if patients must grow their own illicitly.

This realization, in fact, particularly in places like Africa where cannabis has been traditionally and illegally grown.

Which Certifications Count?

This distinction, and not just from crops from Africa, is likely to continue to grow with the increasing tide of cannabis cultivation internationally. 

However, it is unlikely that the pharma standards of GMP will disappear from the medical discussion in places like Europe. Even in places like South Africa, where cannabis is still considered a drug of last resort, the only way that companies can distribute through the medical system is to have the drug licensed in Europe.

Regardless, the African discussion is throwing new themes into an already complex global discussion about cannabinoids, generally, and how they should be classified.

In the meantime, countries like Malawi are creating a domestic infrastructure to support both.

Be sure to stay tuned to the International Cannabis Business Conference blog to learn about global trends affecting the cannabis industry.

Is Cannabis Thailand’s Next Big Cash Crop?

You will be hardpressed to find a region on the planet that has historically been home to harsher cannabis laws than Southeast Asia. Of the seven countries that have imposed the death penalty for cannabis, over half of them are located in this region.

With that in mind, it was a very, very big deal when Thailand announced that it would become the first country in the region to legalize cannabis for medical use back in 2019.

When it was first announced, many cannabis advocates were understandably skeptical regarding how effective Thailand’s medical cannabis program would be given the history of the region.

However, Thailand is now home to one of the most progressive medical programs on earth, at least from a cultivation standpoint. Starting in March of this year, every household in Thailand can cultivate up to 6 plants.

To make it even better, families can form cultivation communities and sell their harvests to public hospitals and state facilities, and use their cannabis crops to make food and cosmetic products to sell.

In addition to helping suffering patients, the Thailand government sees cannabis as being a means for residents to boost their incomes, which was hammered home by recent comments from Thailand’s Health Minister. Per Pattaya Mail:

The Public Health Minister on Saturday visited a cannabis learning center in Bueng Kan province. He said in order to make cannabis production on par with the existing contracts, Thailand might have to have a central agency to collect the statistics of cannabis production and consumption.

He also cited that medicinal herb such as cannabis extracts and medication is becoming popular in Thailand, saying many shops and restaurants are incorporating cannabis in their menus.

In many ways, medical cannabis is being embraced by Thailand, and the country and its residents, especially suffering patients, will no doubt reap the rewards for decades to come as a result.

If/when medical cannabis proves to be an overwhelming success in Thailand hopefully it encourages other countries in the region to step up and get on the right side of history with their own cannabis laws.

Many areas in Southeast Asia are in desperate need of an economic boost. The cannabis industry can provide jobs, increased activity for local economies, and revenue for public coffers for all countries in Southeast Asia if given the chance.

Potential Legalization In Germany – The Hopeful Response From The Cannabis Industry

By Brautinvest.de Editorial Team

How do Germany’s industry leaders view a potential cannabis legalization? We asked around: In overall, the founders and CEOs of successful cannabis companies are hoping for growth opportunities, more control and thus better prevention than on the black market. They point to tax revenues and falling costs for the public budget. At the same time, they discuss the concrete design: Distribution through specialized stores or pharmacies? Cultivation in Germany or imports? And in view of the half-roll backward in Luxembourg – where only home cultivation is legalized – they also point out that nothing is yet set in stone. Critical voices are also being heard: Cannabis is more of a pharmaceutical product, not one for consumption. We were on the hunt for statements.

Growth market, tax revenues and relief for the state budget

Timo Bongartz, General Manager Fluence: “In Germany, we already have a strong ecosystem of companies that can successfully implement cannabis legalization in a structured way. Whether startup or corporation, whether industry, trade or capital provider, the market participants are ready. Now it’s a matter of sounding out politically and socially whether and how to go down the legalization path.”

Niklas Kouparanis, Co-Founder and CEO of Bloomwell Group: “Legalization is clearly on the horizon, even if cannabis will certainly not be legalized overnight in Germany. After all, it is one of the few issues on which all coalition partners are largely in agreement. The crux is the concrete, regulatory demanding, design – I strongly assume a future recreational sale through pharmacies. Product safety for the consumer must be the top priority here. Remind you, in the event of legalization in Germany, we are talking about the largest legal market in the world to date. From a business perspective, it would be negligent not to develop a strategy for this market. ‘The traffic light is green.'”

Benedikt Sons, co-founder and CEO of Cansativa: “Positive! A real growth driver for Germany as a business location: increasing tax revenues and numerous new jobs could boost the German economy. This is accompanied by the relief of the judiciary and authorities through the elimination of petty cannabis-related offenses – these not only swallow up time and paper, but also cost the state an enormous amount of money. From our point of view, the topic of cannabis will soon be socially acceptable, is gaining more and more support, and the task now is to create good conditions for a successful legal cannabis program with the right regulatory framework. Nevertheless, cannabis is not a product without concerns and it is important that dispensing takes place under certain conditions in order to reduce risks of abuse and, in particular, to protect vulnerable people or educate them about dangers.”

Lars Müller, CEO of Synbiotic: “The new government in Germany now gives us additional tailwind once again. The details are not yet known, but we expect a significant step forward in terms of legalization and commercialization.”

Ensuring individual and entrepreneurial freedom

Kai-Friedrich Niermann, lawyer and industry consultant: “The legalization of cannabis is overdue. A new cannabis policy is essential for the state and societal modernization that the new government is announcing. Individual personal freedom and corporate economic freedom of operation, embedded in a well-regulated framework of social responsibility, must be strengthened and failed government repressive policies replaced.”

Controlled dispensing instead of black market excesses

Finn Age Hänsel, founder Sanity Group: “Of course, a lot depends on the regulatory design of the dispensary, but in general I have been fighting for a liberalization of cannabis use for more than 20 years and I am happy to see something moving in politics now. Controlled dispensing and proper regulation solves more problems than continuing to accept the excesses of a growing black market. And by the way a cannabis tax also to plug Corona-related holes in the federal budget without burdening anyone more.”

Tobias Pietsch, owner: “Cannabis legalization is socially indispensable. We will be able to improve many of the problems that have arisen.”

Dr. Adrian Fischer, physician and natural scientist, co-founder and managing director of Demecan: “Instead of blanket legalization, smart deregulation is needed. This includes education and the protection of minors. In addition, there needs to be strict quality controls on cultivation and production, e.g. by the already existing German cannabis agency, which also controls medical cannabis, and a restriction of production to certified producers, ideally from Germany. Of course, cannabis as a stimulant is also a potential billion-dollar market that promises tax revenues and jobs. And in addition, law enforcement agencies and courts could be relieved. However, it is clear that legalization will also have to answer questions such as how to compensate for the actual risks that the healthcare system would face. Or where consumers should obtain cannabis. In licensed specialist stores or in pharmacies that have been dispensing cannabis as a medicine since 2017? One thing is certain: Pharmacists already have the relevant knowledge about the active ingredients, and can assess dose and purity. Because in the end, the goal must be to give citizens access to a controlled, high-quality product and protect them from dangerous goods from the black market.”

Regulatory challenge

Stephen Murphy, CEO & Co-Founder Prohibition Partners: “I do believe the legalisation will proceed in Germany, but both developing and executing the framework will take some time. This is a public health exercise and not an economic one by the government so it will require a more considered approach which is to say that the supply chain won’t vary too much from current expected standards. I’d place a (small) bet on Germany going legal before the US!

Coordination at the European level

Daniel Kruse, entrepreneur and EIHA President: “EIHA welcomes cannabis legalization in Germany, which will provide another boost to the European hemp industry and help end decades of hemp stigma. However, we urge the German government to closely coordinate the new legal framework with its European partners and to advocate for a harmonized commercial hemp and cannabis strategy across Europe. In addition, legalization must be designed to be as socially responsible and fair as possible, including in terms of youth protection, prevention and participation in road traffic.”

More than home cultivation – skepticism remains

Alfredo Pascual, Vice-President of Investment Analysis at Seed Innovations: “It’s still too early to know with certainty when and how adult-use cannabis will be legalized in Germany.

In neighboring Luxembourg, the government promised full-blown legalization in its 2018 Koalitionsvertrag, yet three years later it looks like they will settle on only allowing to grow a few plants at home for personal use, which is a step in the right direction but far from ideal.

I hope that if German policymakers in the new government agree that cannabis should be legalized, that they will have the courage to go beyond what their peers in Luxembourg did.”

Cannabis is a pharmaceutical product

Linus M. Weber – Founder & M.D.: “Cannabis is a legal pharmaceutical product and we need to enforce that more broadly in Germany so that more patients can be treated. For this, legalization as a stimulant is not conducive, but pushes potential prescribers and patients back again. In my opinion, the only right way is to continue to offer cannabis only pharmaceutically. However, whether it must continue to be prescribed or whether products with low THC content can also be made available in pharmacies without a prescription should be examined in detail.”

This article was first published on krautinvest.de in German: https://krautinvest.de/potenzielle-legalisierung-das-hoffnungsvolle-echo-aus-der-cannabis-industrie/

JPMorgan: No Trading Certain U.S. Cannabis Stocks

Cannabis stocks are a popular and easy way to invest in the emerging cannabis industry. As any seasoned investor will point out, cannabis stocks are young compared to stock offerings from more established industries, and the landscape in which those companies operate is always evolving. That creates risk.

To make matters more complicated in the United States, not all cannabis stocks are listed on major stock exchanges. Cannabis, of course, remains illegal at the federal level in the U.S. and that creates even greater risks for certain cannabis companies.

All of that risk, combined with the fallout from the collapse of a private fund, has led JPMorgan to cease all trading of certain U.S.-based cannabis stocks. Per excerpts from an article first published by Reuters:

JPMorgan Chase & Co (JPM.N) has told prime brokerage clients it will no longer let them buy certain U.S. cannabis-related securities beginning Nov. 8, according to a letter seen by Reuters.

“J.P. Morgan (JPMS) has introduced a framework that is designed to comply with U.S. money laundering laws and regulations by restricting certain activities in the securities of U.S. Marijuana Related Businesses,” the bank wrote to clients.

As of Nov. 8, the bank will not allow new purchases or short positions in the related businesses, but clients with existing positions will be allowed to liquidate them, it said.

Cannabis stocks have taken a pounding this year, especially stocks for United States companies. JPMorgan’s announcement could, unfortunately, add to the trend, at least in the immediate future.

Cannabis companies that ‘touch the plant’ and are not listed on the Nasdaq, the New York Stock Exchange, or the Toronto Stock Exchange are subject to JPMorgan’s new policy.

Luxembourg’s Recreational Market Reform Includes Home Grow

What does this mean for the entire discussion across the EU?

Adults in Luxembourg will be permitted to grow up to four cannabis plants in their homes and gardens as part of the emerging details of the country’s legalization program.

The announcement in mid-October certainly blew a breath of fresh if not cannabis-scented air through a debate in Europe which has also seen the European Commission begin to ponder, publicly, if they should rescind their last decision about CBD (namely that it is not a narcotic).

In Luxembourg, however, seed sales will also be permitted with no limit on the level of THC in the same. Sales will also be permitted both in shops and online (which is also no doubt, going to be a boost for the online seed businesses in Europe, starting with Holland.)

Plans also include a system for domestic production of seeds for commercial purposes – but both a national supply chain as well as state-regulated distribution have been repeatedly slowed down by Covid.

Until such plans have been drafted, it remains illegal to consume and trade in cannabis products or plants themselves. The consumption of the same in public and transport of more than three grams still remains a criminal offense. Fines for possession of under three grams will be reduced to about €25.

Legislation to formalize the market is now expected to be introduced in the fall of 2023, with work on the draft law beginning this autumn.

Among the expected issues to be discussed (based on measures already introduced) are a maximum sale amount per month (30 grams), age limits (over 18) and deliveries and online sales are prohibited. Beyond this, purchases will be limited to residents of Luxembourg who have resided in the country for more than 6 months.

There will also be a strictly controlled point of sale infrastructure. Right now, it is expected that there will be 14 points of sale across the country. Products to be sold also must be produced in Luxembourg (in a page out of the Swiss trial).

While the country is a very small one, even for Europe, the impact of the forward motion of this domestic market will be felt throughout the EU. Switzerland is not in the EU (even though it is in Europe). While it is part of a trading alliance with two EU countries (Austria and Germany), regulations here are not tied to approvals by regional authorities. Luxembourg, however, is another kettle of fish.

As a result, progress in Luxembourg is also likely to drive the recreational discussion in other parts of the continent – starting of course in Portugal, but hardly staying there – including of course, pending discussions now underway in Germany as the coalition parties who won the election continue to move towards governing.

Be sure to stay tuned to the International Cannabis Business Conference for more cannabis news from Europe (and beyond).

Polish Hemp Production Is Down – Because Of Government Stays On Incentives

Hemp production fell about 36% this year because many farmers found their state-derived incentives blocked due to supposedly illegal levels of THC

Here is the good news. The Polish government is providing government incentives to the domestic hemp industry. 

Now here is the kicker. The domestic Agency for Restructuring and Modernization of Agriculture (ARiMR) which supports such efforts reduced the amount of money allocated for this activity on the basis that the hemp grown had a level of THC that is verboten.

As a result, hemp fields in cultivation for 2021 numbered just 2,300 hectares, down from 3,600 in 2020 as subsidies have been blocked for the FINOLA oilseed variety (the most popular crop).

The Finnish-based FINOLA is fighting back against this decision as well as the European Commission’s Standing Committee on Plants, Animals and Feed after the EU level agency issued a decision in late July allowing Poland to prohibit the marketing of its seeds.

There is an ongoing battle right now at the European level – namely about how and whether to proceed on a previous decision that CBD was not a narcotic or take a giant step back and reverse its earlier decision.

This hemming and hawing on a regional level is absolutely at play in Poland – particularly because the EC has already signed off on allowing a regional increase of THC from 0.2 – 0.3%. 

However, the domestic government’s stance on the issue creates yet another snag in the pipeline – namely that a regional body and one country in the region (Finland) have already proceeded with the understanding that a higher level of THC would be allowed – and a local one dug in its heels on standing precedent.

This kind of whipsaw is of course not limited to either Poland or hemp. Much of the battle for legalization reform over the next few years will absolutely be to create regional standards and then get these clearly implemented in individual countries. Both strategies will have to be followed – one is not enough. 

Beyond this, of course there are pending lawsuits that also may help change the landscape – but this strategy also has its drawbacks.

Cannabis Reform Is a Hot European Issue

Despite general intransigence and local skirmishes like this one (which have nonetheless proved to be a setback for the thriving Polish hemp industry), there is a new sense on a political level that cannabis reform is coming to Europe and will not be held back. This has been reinforced in the last month with both Switzerland and Luxembourg announcing the next steps to their own recreational markets.

Nonetheless, forward motion is going to be a hard-fought proposition – regionally and locally. This latest contretemps is just one more example.

Be sure to stay tuned to this blog for more trends and analysis of the European cannabis market.

Feiras E Congressos Alavancam A Indústria E Fomentam A Cultura Canábica

This article was originally published by Poder360 and republished here with special permission from the author

By Anita Krepp

Cursos e workshops extraoficiais oferecidos por empreendedores autônomos que viajam para participar do evento principal criam agenda paralela com aulas de cultivo, culinária e extração

Se, mesmo depois de tantos anos, o mistério sobre quem nasceu primeiro, o ovo ou a galinha, ainda não foi definitivamente solucionado, questões de mesmo cunho filosófico, como quem surgiu primeiro, a cultura ou a indústria da cannabis, também estão longe de serem elucidadas. No entanto, uma coisa é certa, a indústria só encontra terreno fértil para crescer e prosperar em uma cultura vibrante e ativa em torno da planta, duas características que as feiras e congressos canábicos cultivam há quase duas décadas, e vem se fortalecendo significativamente de dois anos para cá.

Talvez seja por isso que você anda recebendo cada vez mais convites para participar desse tipo de evento. A indústria já percebeu que o caminho para gerar mais lucro é apostar na formação e no networking de seus atores e consumidores, especialmente por se tratar de um nicho que carece de um rebranding para afastar os antigos preconceitos e de muita educação sobre o que ele de fato é. E apesar do enorme desafio imposto aos realizadores destes eventos durante o confinamento na esteira da pandemia, a indústria seguiu se reunindo e debatendo, ainda que nos últimos meses apenas virtualmente.

Com a volta gradual à normalidade, os eventos presenciais devem reunir um público ainda maior do que em 2019, aposta Alex Rogers, fundador da International Cannabis Business Conference, uma rede internacional de conferências B2B, especialmente porque a maioria das pessoas passou a maior parte do tempo trancafiada em casa e não vê a hora de encontrar seus pares. Mesmo todas as facilidades de um encontro por vídeo não substituem o “cara a cara” na hora de fechar um contrato milionário — somente na International Cannabis Business Conference de 2019, os negócios fechados superam os 100 milhões de dólares. Por isso mesmo, Rogers prepara um espaço de 65 mil m2, o maior até então, para receber mais de 5 mil pessoas na próxima edição, que acontecerá em Berlim, em julho de 2022.

Em meio a centenas de eventos espalhados pelo mundo, alguns de destacam ao catalisar investidores, empresários, produtores e também o público em geral. Um deles, quiçá o de maior expressividade, ocorre na América Latina. O Expocannabis Uruguai acontece no início de dezembro e vem ganhando relevância por se tratar de um país pioneiro na legalização da substância. Isso possibilita, entre outras coisas, o contato direto do público com plantas e flores de cannabis, inclusive com altas concentrações de THC, algo que não é oferecido em nenhum outro lugar, devido às restrições regulamentares ao canabinóide psicoativo.

“Sentir o cheiro da erva e poder sair para uma área reservada dentro do evento para acender um ´baseado´é o tipo de experiência única da Expo Uruguai”, garante Meche Ponce de León, idealizadora e produtora da feira que, desde a primeira edição, em 2014, recebe centenas de brasileiros, que representam o maior público estrageiro. Mas, afinal, o que é que nós vamos buscar na grama do vizinho — que, neste caso, diga-se, é sim infinitamente mais verde? A resposta é simples: experimentar, nem que seja por alguns dias, o gostinho de viver em um ambiente legalizado. Aliás, legalizado e inspirador. Ao passear por vários estandes de empresas de fertilizantes, parafernalhas para autocultivo, óleos medicinais e até banco de sementes, parece que um mundo novo vai surgindo, repleto de possibilidades de negócios que impactariam diretamente a economia não só do país, mas também de gente criativa, ávida por empreender num nicho tão promissor.

Além disso, feiras como essas contam com espaços de socialização, com música e comida, além de um auditório para as conferências e bate-papos a respeito das novidades do mercado, o que envolve saúde, indústria e uso recreativo da erva. Discussões, por exemplo, sobre os efeitos de uma enorme variedade de cepas (espécies de flores de cannabis) que você provavelmente nem sabia que existiam são comuns e muito disputadas.

Legalização não é nada sem cultura

É claro que feiras e congressos são importantes em qualquer outro setor da indústria, mas, quando se trata do incipiente ecossistema da cannabis, são alçadas a um protagonismo único, assumindo um papel fundamental em articulações que envolvem a pressão sobre autoridades, a viabilização de movimentos sociais e a luta dos pacientes, pautas fundamentais para a estruturação e o desenvolvimento do mercado. Estes espaços de promoção do acesso à informação e conhecimento se tornaram cruciais para que potenciais consumidores saibam aquilo que têm à sua disposição, o que naturalmente cria novas demandas de venda.

Somos todos ainda ignorantes — em menor ou maior grau — nos assuntos relacionados à cannabis. Há pouco tempo atrás, até o maconheiro mais raiz pensava que os fungos do prensado paraguaio, o típico “tijolinho de maconha”, modalidade mais difundida no varejo do uso recreativo e de qualidade algo duvidosa, potencializavam os efeitos da erva, quando, na verdade, causam danos ao pulmão. Tamanho equívoco se deve a uma cultura proibicionista, onde, em muitos lugares, apenas tocar no tema é tabu, o que acaba por sufocar a informação e, por conseguinte, a liberdade e as melhores tomadas de decisão. Ignorância, sim, é muito prejudicial à saúde.

Mesmo onde a indústria está legalizada, como na Colômbia, em que gigantescas estufas anteriormente voltadas ao cultivo de rosas agora são destinadas à cannabis, a falta de uma cultura canábica consolidada impossibilita o surgimento de negócios como distribuidores, growshops e bancos de semente, fazendo, assim, com que o debate social seja uma coisa meio morna, e o país seja um eterno predestinado à exportação de insumos. É o resultado que se obtém ao desprezar o potencial crescimento econômico promovido pela cultura da cannabis.

Cultura essa que, aliás, pode mudar de rumo e apontar novos caminhos. Raúl del Pino, da Spannabis, maior evento do ramo na Espanha e um dos mais importantes do mundo desde 2002, sentiu o cheiro de oportunidade no mercado medicinal da planta e não desperdiçou a oportunidade. Ele já prepara o lançamento da CBD Business Fair, específica para produtos de CBD e cânhamo, para outubro do ano que vem.

É pena que, no Brasil, a pobre regulamentação vigente, ainda restrita aos setores abastados da sociedade, siga desprezando os potenciais industriais, econômicos e culturais da erva. Contudo, nem tudo são lástimas. Há um burburinho cultural crescente, estimulado por eventos como o Cannabis Thinking, que promove discussões pertinentes sobre o próprio ecossistema e o networking entre os players da indústria no país. Tudo, porém, sem o cheiro da erva. Aos que ficarem com gostinho de quero mais, resta dar um pulinho no país vizinho.

Agenda paralela dos eventos extraoficiais

O número de turistas brasileiros que cruzam a fronteira para visitar a expo no Uruguai cresce a cada ano, com gente ávida por, digamos, visitar um “salão do automóvel”… com automóvel. Grande parte desse público se une a iniciativas como a Rádio Hemp, que já tem dois ônibus cheios com saída marcada para dezembro, e aos pacotes de viagens oferecidos por agências de turismo canábico, como a MiCasa420. No meio dos entusiastas que pegarão a estrada, há também alguns profissionais e empreendedores canábicos. Eles aproveitam a concentração em um só lugar desse público selecionado para também comercializar seus produtos e serviços. Que sorte, não, poder trabalhar no seu ofício sem correr o risco de ser preso por isso?

Talvez, o que melhor ilustre a formação de uma cultura canábica aconteça justamente para além dos muros do evento oficial. Do lado de dentro, o público está buscando algo específico, tem uma agenda de visitação pré-definida, digamos, estando menos abertos, portanto, ao improviso. Mas, do lado de fora, acontece a mágica. Atividades mais dinâmicas, onde as pessoas se conectam de outra maneira. Todos os dias do evento principal e também nos dias prévios ou seguintes a ele, há uma agenda intensa de atividades. Caio Cézar, do canal Cozinha4e20, sonha em poder fazer uma fornada de brownie e anunciar que vai estar em alguma praça brasileira vendendo seu produto sem, necessariamente, arrumar problemas por isso. Mas, enquanto essa possibilidade não se realiza, Cézar viaja ao Uruguai, aluga uma casa e monta um menu com infusão de cannabis para receber os convidados pagantes deste jantar.

Festas, noites temáticas de drinks ou brownies com cannabis, rodízios de pizza, e tudo isso regado a muito papo que metalinguisticamente discute a própria cultura canábica gerada naquele lugar. No dia seguinte, city tour canábico e vários cursos e workshops de culinária, extração e cultivo da terra. Se, antes, os jovens trocavam figurinhas sobre qual boca de fumo era menos perigosa ou onde o fumo estava mais em conta, hoje começam a falar sobre cultivo, pH da água, substratos e técnicas de germinação. Pelo visto, a difusão da cultura canábica não só fomenta a economia, como também traz uma nova perspectiva para a garotada. Ao que tudo indica, é só questão de tempo para o famigerado prensado paraguaio virar peça de museu.

Survey Finds That People Prefer To Live In Legal Cannabis Jurisdictions

The adult-use cannabis reform ‘experiment’ has been underway in the United States since 2012 when voters in Colorado and Washington State approved legalization initiatives on Election Day.

Leading up to the successful votes in 2012 opponents pulled out all of the stops in an attempt to keep prohibition in place, including hurling unfounded theories that cannabis legalization and the industry it created would ruin both states.

Since 2012, many other states have also legalized cannabis for adult use and obviously, the sky has not fallen over any of them. In fact, a plurality of survey participants recently indicated that they prefer to live in legalized jurisdictions.

Below is more information about it via a news release from our friends at NORML:

A plurality of US adults desire to reside in a jurisdiction where “marijuana is fully legal.”

In a survey of new movers compiled by the real estate brokerage firm Redfin, 46 percent of respondents said that they would either “prefer” to live in a jurisdiction where cannabis was legal or that they would “only” live in a legalization state. Twenty-two percent of respondents did not want to reside in a legal state. Thirty-two percent of respondents had no opinion.

Studies have previously reported that cannabis legalization is correlated with increased property values. Data reported in July concluded, “[T]here is strong evidence that legalization drives higher property values — particularly in areas that allow recreational marijuana and welcome retail dispensaries. … These investments can improve quality of life in communities across the nation while attracting tourism and new residents who drive real estate demand.”

Separate data have shown that states experienced spikes in tourism following adult-use legalization.

Additional information is available in the NORML fact sheet, ’Marijuana Regulation: Impact on Health, Safety, Economy.’

Switzerland And Luxembourg Firm Plans For Recreational Markets

Two European countries, one in the EU and one surrounded by it are, after many stutters and false starts, moving concretely towards recreational markets next year.

In the last week, both Switzerland and Luxembourg have made concrete plans to formalize their recreational plans for 2022. This may indeed prove to be Europe’s tipping point year, much akin to 2014 in the US when both Colorado and Washington State defied US federal law and moved forwards with their own recreational markets.

With Holland formalizing its recreational market, and Portugal also now at a tipping point, even if much delayed, the conversation about recreational cannabis has hit Europe. 

What this will mean, however, is a different conversation.

Most if not all investment funds (for example) are still publicly at least, only talking about medical cannabis investments. 

In a blended market like Switzerland, however, this may make increasingly little difference.

Medical Vs. Recreational Production and Certification

One thing is for sure. The level of certification issued for such markets will be done at a federal level. This means, by definition, that the level of quality will be much higher than what was initially seen in the US.

In Switzerland, pharmacies will carry both kinds of products. This means that even recreational products will have to pass federal quality tests still unseen in America.

Impact on Other EU Markets

All this is happening of course at a time when Germany, still Europe’s largest medical cannabis market, is now considering the next course of cannabis reform. It is highly likely in the next two years, that the coalition government that seems to be formalizing, will at least decriminalize the plant. 

However, with trial projects going on all around it, it is also unlikely that Germany will be able to resist the clarion call for a recreational trial within the next four years. The FDP, for one, are clear about their desire for tax money that could come from the market. This will become an increasingly interesting proposition as the ravages of both Covid and the subsequent supply chain discussions now hitting the world.

Beyond this, there are clearly other EU countries hovering around this discussion even if they have not formally announced the same. This includes the Czech Republic. It may also include places like Italy and Malta where home grow is now legit, not to mention Spain.

The future indeed seems to look brighter and brighter, and it is very clear that this time it is not just another train.

Stay tuned to the International Cannabis Business Conference blog for developments about the global cannabis industry.